Stanniocalcin 2 drives malignant transformation of human glioblastoma cells by targeting SNAI2 and Matrix Metalloproteinases
Glioblastoma multiforme (GBM) is the most malignant brain tumor and is refractory to conventional therapies. Although previous studies have proposed that the interaction between gene mutations and the external environment leads to the occurrence of GBM, the pathogenesis of GBM is still unclear and m...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2022
|
Online Access: | View Fulltext in Publisher |